A lot of that falls right into the same realm that we've been talking about, which is data management and a lack of data management in the majority of the departments. They're not following up to find out whether they're using the right drugs or whether or not the strategies they've put in place are effective.
That carries right over into my next question, which is based on the venture capital action plan. We talk about data management, and I feel as though this entire action plan was flawed from the get-go and that they didn't even absorb the data that was out there departmentally before starting this program.
I have no idea about the amount of fees that should be applied to fund managers over the lifetime of the plan, but your comments said that one of the flaws was the double layer of management and how that could affect the performance and give less control of capital to the limited partners. You also said that the exit strategy was probably not the best strategy to start with and that there were other fund models that used a strategy that allowed the public sector to withdraw from it before the completion of the program.
I feel that this data management problem is broad and is across all departments, and that maybe we need to dig into that more.